9/10/23 Update
9 October 2023We received Andy's liver biopsy results last week, she does not qualify for Cetuximab (Erbitux) but does qualify for Bevacizumab (Avastin). On advice from her nutritionist, she has decided to pursue prescribed medications that are researched to work on the same pathways as Avastin alongside her current alternative health treatments for the next 4 rounds of chemotherapy (until late November). At that point, she will have another CT scan which will determine her next course of action - whether she will continue her current treatment or pursue targeted immunotherapy treatment.
Follow her highlights "update 3" on Instagram @andyheartthrob for more details